Loading Reports

Market research reports on:  Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.

Let's Connect
188 Reports in Pharmaceuticals

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Cardiovascular Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM191A

The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.

Small Molecule Therapies for Rheumatoid Arthritis: Global Markets...

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM195A

The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Anti-Parkinson's Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM193A

The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.

Substance Abuse and Addiction Treatment, Global Markets to 2021

Published - Aug 2017 | Publisher - BCC Publishing| Code - PHM035C

The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

Antibody Drug Conjugates: Technologies and Global Markets

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM161B

The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.

The Chinese Market for Cancer Intervention

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM179A

The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM026C

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Global Markets for Neglected Tropical Disease Treatments

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM180A

The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.

Smart Pills: Applications and Global Markets

Published - May 2017 | Publisher - BCC Publishing| Code - PHM181A

The global market for smart pills reached $720 million in 2015. This market is expected to increase from $850 million in 2016 to $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 21.1% for 2016-2021. 

Cancer Immunology and Oncolytic Virology: Technologies and Global...

Published - May 2017 | Publisher - BCC Publishing| Code - PHM129B

The global cancer immunotherapy market should reach $96.5 billion by 2021 from $73.0 billion in 2016 at a compound annual growth rate (CAGR) of 5.7%, from 2016 to 2021.

Infectious Disease Drugs: The Chinese Market

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM178A

The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Mark...

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM050C

The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.

Breakthrough Therapies: Market Dynamics and Investment Opportunit...

Published - Jan 2017 | Publisher - BCC Publishing| Code - PHM176A

The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.

Radiopharmaceuticals: Technologies and Global Markets

Published - Jan 2017 | Publisher - BCC Publishing| Code - PHM171B

The global market radiopharmaceuticals were valued at nearly $5.1 billion and $5.7 billion in 2014 and 2015, respectively. This market is expected to increase from nearly $6.5 billion in 2016 to $11.6 billion in 2021 at a compound annual growth rate (CAGR) of 12.4% for 2016-2021.

Therapies for Rheumatoid Arthritis: Technologies and Global Marke...

Published - Jul 2016 | Publisher - BCC Publishing| Code - PHM072A

The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound annual growth rate (CAGR) of 1.3% from 2015 to 2020.

Personalized Medicine and Epigenomics: Technologies and Global Ma...

Published - Mar 2016 | Publisher - BCC Publishing| Code - PHM044C

The global epigenomic market reached nearly $4 billion in 2014 and $4.7 billion in 2015. The market should reach nearly $12.1 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 20.6% from 2015 to 2020.

Global Markets for Drug Repurposing

Published - Jan 2016 | Publisher - BCC Publishing| Code - PHM175A

The global market for drug repurposing will grow from nearly $24.4 billion in 2015 to nearly $31.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.1% for the period of 2015-2020.

Skin Disease Treatment Technologies and Global Markets

Published - Jan 2016 | Publisher - BCC Publishing| Code - PHM127B

The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.

Erythropoietin Stimulating Agents: Therapeutic Applications and G...

Published - Jan 2016 | Publisher - BCC Publishing| Code - PHM130A

The global market for erythropoietin stimulating agents (ESAs) will grow from nearly $7.2 billion in 2015 to nearly $7.3 billion by 2020 with a compound annual growth rate (CAGR) of 0.2% for the period 2015-2020.

Ophthalmic Therapeutic Drugs: Technologies and Global Markets

Published - Jul 2015 | Publisher - BCC Publishing| Code - PHM031D

The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2019, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2019.

Liver Disease Treatments: The Global Market

Published - Jun 2015 | Publisher - BCC Publishing| Code - PHM057C

The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

Diagnostics and Therapeutics for Lung Cancer: Global Markets

Published - May 2015 | Publisher - BCC Publishing| Code - PHM174A

The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.

Incretin-Based Drugs: Markets for Diabetes Therapies and Developi...

Published - Feb 2015 | Publisher - BCC Publishing| Code - PHM162A

The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019.

Therapeutics for 'Silent' Cancers

Published - Feb 2015 | Publisher - BCC Publishing| Code - PHM169A

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

« 4 5 6 7 8 »
Upcoming reports for this category are not yet released. The titles will be made available closer to the time of launch.
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM

 

Download Catalog